Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
about
Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencingc-Met as a Target for Personalized TherapyFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersThe AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.Prioritizing therapeutic targets using patient-derived xenograft modelsMET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic targetComprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell CarcinomaEpidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma.Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinomaEnhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation.miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.Genomic alterations in advanced esophageal cancer may lead to subtype-specific therapies.MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas.High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagusSynergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells.C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome.Subcellular localization of EGFR in esophageal carcinoma cell lines.Chromosomal and Genomic Variations in Esophageal Squamous Cell Carcinoma: A Review of Technologies, Applications, and Prospections.Expression, Mutation, and Amplification Status of EGFR and Its Correlation with Five miRNAs in Salivary Gland Tumours.FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma.Identification and validation of FGFR2 peptide for detection of early Barrett's neoplasia.
P2860
Q26768533-90DE66D1-FAA0-4E2A-B6E0-A4D4C14C208EQ26775483-34602B80-3C9C-4849-B246-84E171139BA8Q26998955-3BE36F18-0340-4E6C-A15A-497E3344ED25Q27853383-DF91D1A9-B423-4165-B6C8-20F02D5D6AE1Q28083993-D6BA01DF-4FFE-40E5-9F3C-1B492EA8FE5DQ33688421-80706CD7-2384-46DA-B27F-9380195064CAQ35624456-599C9655-D66D-4F24-8C44-64C4C6D462B6Q35650167-E08ADD65-C4D6-4326-A2CC-FCFB37A67D6AQ35763725-317800AB-CFAF-46C0-96C1-6294D05F56F7Q35805987-9255BEE1-F30E-4710-AA30-3DFFA3AF297FQ36172082-B42FEFA9-D123-4E24-A175-B01EC92F68F1Q36503276-BE12AC8D-70FB-448F-BDE3-075F3487AB79Q36737108-4F10AD87-9F50-464A-9EEF-9717A88A0301Q36983766-377AD0E9-ED65-48FC-BE1A-83335944488AQ37038482-09B308B0-FAE8-4AFE-9C02-C98C73698893Q37457633-B361BE27-4D09-4EF4-AB46-F11E12ED348DQ37475210-DC2F3EB8-A095-422A-8642-B655BC970C74Q37522222-DB578145-0AB7-4509-98C3-908AED33176AQ37593285-8596637F-BDED-4BBB-9AE4-6787DE195DAEQ37609759-9408F3CC-9758-4EEE-9254-F215D6AB22C8Q38856978-167E9E42-1F91-496C-8893-BD6F4B474447Q39866108-830FB053-2F13-48DB-807A-9C1BCE140CE3Q40784649-65E5DFF0-D38D-4AD1-A2B9-80588ABC4090Q41243136-660E7215-F7FD-4001-AC63-A829AE75FAF8Q42314672-1F1B443A-B4EC-4977-9AC7-65E25286B9F8Q46313987-4EC42C44-9261-4052-A26A-909BEE9B9F2BQ47134720-573D59F5-474B-487C-AB5F-D5A540202286
P2860
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
@ast
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
@en
type
label
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
@ast
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
@en
prefLabel
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
@ast
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
@en
P2093
P2860
P356
P1476
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma.
@en
P2093
Atsushi Yasuda
Haruhiko Imamoto
Hideharu Kimura
Hidetoshi Hayashi
Hiroaki Kato
Hitoshi Shiozaki
Kazuko Matsumoto
Kazuto Nishio
Kiyotaka Okuno
Kouhei Nishiki
P2860
P304
P356
10.3892/IJO.2013.1830
P577
2013-02-19T00:00:00Z